Evidence map›Paper›PMID 33311639›Full record

ArticleCommunications biology2020

Nasopharyngeal carcinoma MHC region deep sequencing identifies HLA and novel non-HLA TRIM31 and TRIM39 loci.

Lvwen Ning, Josephine Mun-Yee Ko, Valen Zhuoyou Yu, Hoi Yan Ng, Candy King-Chi Chan, Lihua Tao, Shiu-Yeung Lam, Merrin Man-Long Leong, Roger Kai-Cheong Ngan, Dora Lai-Wan Kwong and 11 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Multifaceted role ofMedComm · 2024
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 2 countries.

Lvwen NingDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Josephine Mun-Yee KoDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China. joko@hku.hk.ORCID 0000-0002-7997-331X
Valen Zhuoyou YuDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Hoi Yan NgDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Candy King-Chi ChanDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Lihua TaoDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Shiu-Yeung LamDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.ORCID 0000-0003-3001-3112
Merrin Man-Long LeongDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Roger Kai-Cheong NganCenter for Nasopharyngeal Carcinoma Research, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Dora Lai-Wan KwongDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Anne Wing-Mui LeeDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Wai-Tong NgCenter for Nasopharyngeal Carcinoma Research, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Ashley ChengCenter for Nasopharyngeal Carcinoma Research, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Stewart TungCenter for Nasopharyngeal Carcinoma Research, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.ORCID 0000-0002-2527-6471
Victor Ho-Fun LeeDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Ka-On LamDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.ORCID 0000-0002-7523-5088
Chung-Kong KwanDepartment of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong (Special Administrative Region), People's Republic of China.
Wing-Sum LiDepartment of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong (Special Administrative Region), People's Republic of China.
Stephen YauDepartment of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong (Special Administrative Region), People's Republic of China.
Jin-Xin BeiSun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060, Guangzhou, People's Republic of China.ORCID 0000-0003-1333-407X
Maria Li LungDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China. mlilung@hku.hk.
University of Hong Kong · HKQueen Elizabeth Hospital · CNHKU-Pasteur Research Pole · HKPamela Youde Nethersole Eastern Hospital · CNSun Yat-sen University · CNTuen Mun Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite pronounced associations of major histocompatibility complex (MHC) regions with nasopharyngeal carcinoma (NPC), causal variants underlying NPC pathogenesis remain elusive. Our large-scale comprehensive MHC region deep sequencing study of 5689 Hong Kong Chinese identifies eight independent NPC-associated signals and provides mechanistic insight for disrupted transcription factor binding, altering target gene transcription. Two novel protective variants, rs2517664 (T

Indexed as

Genetic Predisposition to DiseaseGenetic VariationAgedAllelesAmino Acid SubstitutionCase-Control StudiesFemaleGenetic HeterogeneityGenetic TestingGenome-Wide Association StudyHaplotypesHigh-Throughput Nucleotide SequencingHistocompatibility Antigens Class IHLA AntigensHumansINDEL MutationHistocompatibility Antigens Class IHLA AntigensTRIM31 protein, humanTRIM39 protein, humanTripartite Motif ProteinsUbiquitin-Protein Ligases

Identifiers

PMID33311639
PMCPMC7733486
OpenAlexW3112798965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.